BioMarin Pharmaceutical
BMRN
#1113
Rank
$16.38 B
Marketcap
$86.85
Share price
-1.99%
Change (1 day)
-5.08%
Change (1 year)

Operating Margin for BioMarin Pharmaceutical (BMRN)

Operating Margin as of March 2024 (TTM): 4.83%

According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 4.83%. At the end of 2022 the company had an Operating Margin of 7.14%.

Operating Margin history for BioMarin Pharmaceutical from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
20227.14%-274.85%
2021-4.08%79.41%
2020-2.27%-59.11%
2019-5.56%-41.86%
2018-9.57%250.42%
2017-2.73%-96.33%
2016-74.41%327.97%
2015-17.39%4.58%
2014-16.63%-48.33%
2013-32.18%36.23%
2012-23.62%138.97%
2011-9.88%73.07%
2010-5.71%-3376.03%
20090.17%-98.45%
200811.27%-190.92%
2007-12.40%-57.68%
2006-29.30%-88.29%
2005-250.16%-68.47%
2004-793.48%26.66%
2003-626.47%28.95%
2002-485.84%41.03%
2001-344.49%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
18.21% 277.02%๐Ÿ‡ซ๐Ÿ‡ท France
-162.16%-3,457.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-160.78%-3,428.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-343.04%-7,202.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-55.07%-1,240.17%๐Ÿ‡บ๐Ÿ‡ธ USA
48.88% 912.01%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.